ISARIC COVID-19 Clinical Data Report: 20 November 2020
By
Matthew David Hall,
Mark G Pritchard,
Emmanuelle Dankwa,
J Kenneth Baillie,
Gail Carson,
Barbara Wanjiru Citarella,
Annemarie B Docherty,
Christl A Donnelly,
Jake Dunning,
Christophe Fraser,
Hayley Hardwick,
Ewen M Harrison,
Karl Holden,
Christiana Kartsonaki,
Kalynn Kennon,
James Lee,
Kenneth McLean,
Peter JM Openshaw,
Daniel R Plotkin,
Amanda Rojek,
Clark D Russell,
Malcolm G Semple,
Louise Sigfrid,
Susan Smith,
Peter Horby,
Piero L Olliaro,
Laura Merson
Posted 25 Jul 2020
medRxiv DOI: 10.1101/2020.07.17.20155218
ISARIC (International Severe Acute Respiratory and emerging Infections Consortium) partnerships and outbreak preparedness initiatives enabled the rapid launch of standardised clinical data collection on COVID-19 in Jan 2020. Extensive global uptake of this resource has resulted in a large, standardised collection of comprehensive clinical data from hundreds of sites across dozens of countries. Data are analysed regularly and reported publicly to inform patient care and public health response. This report is a part of a series and includes the results of data analysis on 20 November 2020. We thank all of the data contributors for their ongoing support. Report highlights include: ISARIC collaborators recorded symptoms from over 122,000 patients in hospital with COVID-19. Most had fever, cough or shortness of breath. Children and older adults were less likely to display typical symptoms, and over 40% of patients >80 years experienced confusion. The ISARIC international database continues to grow. Data have been entered for 122,361 individuals from 578 sites across 42 countries. The analysis detailed in this report only includes individuals: 1. for whom data collection commenced on or before 26 October 2020. AND 2. who have laboratory-confirmed or clinically-diagnosed SARS-COV-2 infection. For the 95,966 cases who meet eligibility criteria for this report: o The median age is 72 years. o A total of 20% of patients were admitted at some point during their illness into an intensive care unit. o Antibiotic use is high (81.9% of patients received antibiotics - the choice of antibiotic and specific indication have not yet been determined.) o Fever, shortness of breath, a non-productive cough and fatigue were the most common symptoms. o Altered consciousness/confusion was also relatively frequent (20,802/95,079) and most common in elderly patients. Overall, elderly patients are less likely to present with URTI symptoms. To access previous versions of ISARIC COVID-19 Clinical Data Report please use the link below: https://isaric.org/research/covid-19-clinical-research-resources/evidence-reports/
Download data
- Downloaded 1,821 times
- Download rankings, all-time:
- Site-wide: 7,375
- In infectious diseases: 900
- Year to date:
- Site-wide: None
- Since beginning of last month:
- Site-wide: 2,477
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!